HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

C Twelves Selected Research

capecitabine (Xeloda)

5/2012Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.
12/2011Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients.
1/2011Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer.
9/2006Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?
4/2006Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial.
2/2006A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer.
12/2003Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial.
11/2002The rational development of capecitabine from the laboratory to the clinic.
10/2002Capecitabine named-patient programme for patients with advanced breast cancer. the UK experience.
4/2002First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


C Twelves Research Topics

Disease

18Colorectal Neoplasms (Colorectal Cancer)
03/2014 - 03/2000
10Breast Neoplasms (Breast Cancer)
08/2014 - 05/2000
7Neoplasms (Cancer)
09/2012 - 03/2000
6Stomatitis
04/2008 - 03/2001
6Neutropenia
11/2004 - 11/2001
5Colonic Neoplasms (Colon Cancer)
05/2015 - 11/2002
5Nausea
04/2008 - 02/2002
4Diarrhea
04/2008 - 03/2000
4Vomiting
01/2007 - 01/2003
4Alopecia (Baldness)
12/2003 - 11/2001
4Sepsis (Septicemia)
12/2003 - 11/2001
3Fever (Fevers)
04/2002 - 11/2001
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014 - 11/2010
2Fatigue
04/2008 - 12/2004
2Disease Progression
04/2002 - 11/2001
1Chromosomal Instability (Chromosome Stability)
06/2012
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2011
1Stomach Neoplasms (Stomach Cancer)
12/2011
1Exanthema (Rash)
04/2008
1Prostatic Neoplasms (Prostate Cancer)
01/2006
1Neoplasm Metastasis (Metastasis)
01/2005
1Carcinoma (Carcinomatosis)
12/2003
1Phlebitis
09/2003
1Adenocarcinoma
08/2003
1Glioblastoma (Glioblastoma Multiforme)
05/2002
1Hyperbilirubinemia
11/2001
1Drug Toxicity (Drug Safety)
03/2001
1Kidney Neoplasms (Kidney Cancer)
01/2001
1Renal Cell Carcinoma (Grawitz Tumor)
01/2001
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2001
1Asthenia
07/2000

Drug/Important Bio-Agent (IBA)

17capecitabine (Xeloda)FDA Link
05/2012 - 03/2000
13Fluorouracil (Carac)FDA LinkGeneric
05/2012 - 01/2001
12Leucovorin (Folinic Acid)FDA Link
05/2012 - 03/2000
4oxaliplatin (Eloxatin)FDA LinkGeneric
01/2009 - 10/2003
3Paclitaxel (Taxol)FDA LinkGeneric
01/2014 - 07/2002
3docetaxel (Taxotere)FDA Link
09/2006 - 07/2000
3TransaminasesIBA
12/2004 - 09/2003
2CytotoxinsIBA
09/2012 - 01/2001
2taxaneIBA
01/2011 - 11/2002
2irinotecan (Camptosar)FDA LinkGeneric
03/2007 - 08/2003
2TaxoidsIBA
09/2006 - 01/2001
2Alkaline PhosphataseIBA
12/2004 - 09/2003
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2004 - 07/2002
2BilirubinIBA
09/2003 - 01/2003
2acridine DACAIBA
01/2003 - 05/2002
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2002 - 01/2001
2thymidine 5'-triphosphate (TTP)IBA
03/2001 - 03/2000
1Sodium Glutamate (Accent)IBA
05/2015
1Epidermal Growth Factor Receptor (EGF Receptor)IBA
08/2014
1axitinib (AG 013736)IBA
01/2014
1Carboplatin (JM8)FDA LinkGeneric
01/2014
1bevacizumabFDA Link
01/2014
1AnthracyclinesIBA
06/2012
1TubulinIBA
01/2011
12- (3- amino- 2- hydroxypropyl)hexacosahydro- 3- methoxy- 26- methyl- 20,27- bis(methylene)11,15- 18,21- 24,28- triepoxy- 7,9- ethano- 12,15- methano- 9H,15H- furo(3,2- i)furo(2',3'- 5,6)pyrano(4,3- b)(1,4)dioxacyclopentacosin- 5- (4H)- oneIBA
01/2011
1erlotinib (CP 358,774)FDA Link
11/2010
1pemetrexed (MTA)FDA Link
11/2010
1bortezomib (Velcade)FDA Link
01/2009
1Thymidylate SynthaseIBA
04/2008
1((S)- 2- (5- (1,2- dihydro- 3- methyl- 1- oxobenzo(f)- quinazoline- 9- yl)methyl)amino- 1- oxo- 2- isoindolynyl)- glutaric acidIBA
04/2008
1CreatinineIBA
01/2007
1HormonesIBA
01/2006
1sabarubicin (MEN 10755)IBA
01/2006
1CGS 27023AIBA
01/2005
1mistletoe lectin IIBA
12/2004
1Viscum ribosome inactivating proteinIBA
12/2004
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
12/2004
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2003
1TegafurIBA
08/2003
1UracilIBA
08/2003
1DNA (Deoxyribonucleic Acid)IBA
05/2002
1Type I DNA Topoisomerases (Topoisomerase I)IBA
05/2002
1tebufenozide (Mimic)IBA
11/2001
1Thymidine PhosphorylaseIBA
01/2001

Therapy/Procedure

10Drug Therapy (Chemotherapy)
12/2011 - 01/2001
1Infusion Pumps (Infusion Pump)
03/2014
1Ambulatory Care (Outpatient Care)
05/2000